These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30303710)

  • 41. A nomogram for predicting the risk of new-onset albuminuria based on baseline urinary ACR, orosomucoid, and HbA1c in patients with type 2 diabetes.
    Xu Y; Shan X; Wang H
    J Diabetes Complications; 2021 Dec; 35(12):108058. PubMed ID: 34635404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
    Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
    Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Serum Uric Acid Concentration with Diabetic Retinopathy and Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus.
    Liang CC; Lin PC; Lee MY; Chen SC; Shin SJ; Hsiao PJ; Lin KD; Hsu WH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Characterization of Serum Docosahexaenoic Acid and Its Relationship With Inflammation Factors in Patients With Diabetic Nephropathy.
    Zhou L; Yao D; Zhao S; Jiang Y; Lu W
    Iran J Kidney Dis; 2018 Mar; 12(2):91-98. PubMed ID: 29507271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
    Penno G; Garofolo M; Del Prato S
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is Uric Acid elevation a random finding or a causative agent of diabetic nephropathy?
    Kocak MZ; Aktas G; Duman TT; Atak BM; Savli H
    Rev Assoc Med Bras (1992); 2019; 65(9):1155-1160. PubMed ID: 31618330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary excretion of uric acid is negatively associated with albuminuria in patients with chronic kidney disease: a cross-sectional study.
    Li F; Guo H; Zou J; Chen W; Lu Y; Zhang X; Fu C; Xiao J; Ye Z
    BMC Nephrol; 2018 Apr; 19(1):95. PubMed ID: 29699501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FABP1 and FABP2 as markers of diabetic nephropathy.
    Tsai IT; Wu CC; Hung WC; Lee TL; Hsuan CF; Wei CT; Lu YC; Yu TH; Chung FM; Lee YJ; Wang CP
    Int J Med Sci; 2020; 17(15):2338-2345. PubMed ID: 32922199
    [No Abstract]   [Full Text] [Related]  

  • 51. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.
    El-Samahy MH; Adly AA; Elhenawy YI; Ismail EA; Pessar SA; Mowafy ME; Saad MS; Mohammed HH
    J Diabetes Complications; 2018 Feb; 32(2):185-192. PubMed ID: 29175120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP).
    Bose S; Bomback AS; Mehta NN; Chen SC; Li S; Whaley-Connell A; Benjamin J; McCullough PA;
    BMC Nephrol; 2012 Sep; 13():104. PubMed ID: 22958709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum obestatin and omentin levels in patients with diabetic nephropathy.
    Zorlu M; Kiskac M; Güler EM; Gültepe I; Yavuz E; Çelik K; Kocyigit A
    Niger J Clin Pract; 2017 Feb; 20(2):182-187. PubMed ID: 28091434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.
    Hunt KJ; Jenkins AJ; Fu D; Stevens D; Ma JX; Klein RL; Azar M; Zhang SX; Lopes-Virella MF; Lyons TJ;
    J Diabetes Complications; 2019 Oct; 33(10):107410. PubMed ID: 31434620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
    Takashima H; Yoshida Y; Nagura C; Furukawa T; Tei R; Maruyama T; Maruyama N; Abe M
    Diab Vasc Dis Res; 2018 Sep; 15(5):469-472. PubMed ID: 29923427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered serum levels of FGF-23 and magnesium are independent risk factors for an increased albumin-to-creatinine ratio in type 2 diabetics with chronic kidney disease.
    Silva AP; Mendes F; Fragoso A; Jeronimo T; Pimentel A; Gundlach K; Büchel J; Santos N; Neves PL
    J Diabetes Complications; 2016 Mar; 30(2):275-80. PubMed ID: 26750742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study.
    Uehara Y; Makino H; Seiki K; Urade Y;
    Nephrol Dial Transplant; 2009 Feb; 24(2):475-82. PubMed ID: 18799608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?
    Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O
    Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of serum adiponectin level with albuminuria in chronic kidney disease patients.
    Kim HY; Bae EH; Ma SK; Chae DW; Choi KH; Kim YS; Hwang YH; Ahn C; Kim SW
    Clin Exp Nephrol; 2016 Jun; 20(3):443-9. PubMed ID: 26445954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.